Neures Polskasp. z o.o.
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Overview
Neures Polska provides therapy in Warsaw for autism spectrum disorders, sensory integration disorders and ADHD using Neures suits. Founded in 2017, the company conducts research into applying this therapy to neurological conditions, including Parkinson’s disease and multiple sclerosis.
Financials
The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-01-16. Active
53 1020 1127 0000 1902 0287 3883
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
70 public aid cases recorded, with a total value of $25,220.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 9, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $419$419 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Mar 12, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $419$419 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Feb 12, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $419$419 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
To submit declarations of will on behalf of the company, joint action of two members of the management board, or a member of the management board and a commercial proxy acting jointly, is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Leszek Maciej Abakumow (63) | 269 | $3,633.17 | 53.8% |
Przemysław Andrzej Jaśkiewicz (53) | 73 | $985.95 | 14.6% |
Krzysztof Jan Woźnicki (57) | 147 | $1,985.41 | 29.4% |
Others | 11 | $148.57 | 2.2% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| QvitiS.A. | $588,092.81 | qviti.com | ||
| Silsense TechnologiesS.A. | $444,795.89 | silsense.pl | ||
| ScansoftS.A. | $29,054.12 | healthnomic.pl | ||
| Proemdrsp. z o.o. | $25,254.32 | proemdr.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-11-10 | Share capital change (24,000.00 PLN → 25,000.00 PLN) | |
| 2020-10-21 | Address change (Ul. Przasnyska 6a/231, 01-756, Warszawa → Ul. Mrówcza 165/Parter, 04-892, Warszawa) | |
| 2019-08-27 | Share capital change (5,000.00 PLN → 24,000.00 PLN) | |
| 2019-02-06 | Address change (Ul. Anny German 15, 01-794, Warszawa → Ul. Przasnyska 6a/231, 01-756, Warszawa) | |
| 2017-12-28 | Entered in the register |
FAQ
Last updated: 2026-04-27